Hydroxytyrosol in the Prevention of the Metabolic Syndrome and Related Disorders
- PMID: 28335507
- PMCID: PMC5372969
- DOI: 10.3390/nu9030306
Hydroxytyrosol in the Prevention of the Metabolic Syndrome and Related Disorders
Abstract
Virgin olive oil (VOO) constitutes the main source of fat in the Mediterranean diet. VOO is rich in oleic acid, displaying health-promoting properties, but also contains minor bioactive components, especially phenolic compounds. Hydroxytyrosol (HT), the main polyphenol of olive oil, has been reported to be the most bioactive component. This review aims to compile the results of clinical, animal and cell culture studies evaluating the effects of HT on the features of Metabolic Syndrome (MetS) (body weight/adiposity, dyslipidemia, hypertension, and hyperglycemia/insulin resistance) and associated complications (oxidative stress and inflammation). HT was able to improve the lipid profile, glycaemia, and insulin sensitivity, and counteract oxidative and inflammatory processes. Experimental studies identified multiple molecular targets for HT conferring its beneficial effect on health in spite of its low bioavailability. However, rodent experiments and clinical trials with pure HT at biologically relevant concentrations are still lacking. Moreover, the roles of intestine and its gut microbiota have not been elucidated.
Keywords: body weight; dyslipidemia; hydroxytyrosol; hyperglycemia; hypertension; inflammation; oleuropein; olive oil; oxidative stress; tyrosol.
Conflict of interest statement
The authors declare no conflict of interest.
Figures

References
-
- Alberti K.G.M.M., Eckel R.H., Grundy S.M., Zimmet P.Z., Cleeman J.I., Donato K.A., Fruchart J.-C., James W.P.T., Loria C.M., Smith S.C., Jr., et al. Harmonizing the metabolic syndrome: A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120:1640–1645. - PubMed
-
- Laslett L.J., Alagona P., Clark B.A., Drozda J.P., Saldivar F., Wilson S.R., Poe C., Hart M. The worldwide environment of cardiovascular disease: Prevalence, diagnosis, therapy, and policy issues: A report from the American College of Cardiology. J. Am. Coll. Cardiol. 2012;60:S1–S49. doi: 10.1016/j.jacc.2012.11.002. - DOI - PubMed
-
- Estruch R., Ros E., Salas-Salvadó J., Covas M.-I., Corella D., Arós F., Gómez-Gracia E., Ruiz-Gutiérrez V., Fiol M., Lapetra J., et al. Study Investigators Primary prevention of cardiovascular disease with a Mediterranean diet. N. Engl. J. Med. 2013;368:1279–1290. doi: 10.1056/NEJMoa1200303. - DOI - PubMed
-
- Covas M.-I., Ruiz-Gutiérrez V., de la Torre R., Kafatos A., Lamuela-Raventós R.M., Osada J., Owen R.W., Visioli F. Minor Components of Olive Oil: Evidence to Date of Health Benefits in Humans. Nutr. Rev. 2006;64:S20–S30. doi: 10.1111/j.1753-4887.2006.tb00260.x. - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical